Austar Lifesciences Limited (HKG:6118)

Austar Lifesciences Revenue

Austar Lifesciences had revenue of 744.48M CNY in the half year ending June 30, 2026, with 6.22% growth. This brings the company's total for the last twelve months to 1.61B, up 10.39% year-over-year. In the year 2025, Austar Lifesciences had annual revenue of 1.53B with 2.02% growth. That makes Austar Lifesciences the 16,184th largest company in the world by revenue and 950th in Hong Kong.

• Revenue (ttm): 1.61B CNY
• Revenue Growth: +10.39%
• P/S Ratio: 0.17
• Revenue / Employee: 1.08M CNY
• Employees: 1,490
• Market Cap: 317.80M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart

• Integrated Process and Packaging Equipment & Systems 1.01B 54.5%
• Consulting,digitalization and Construction 509.58M 27.6%
• Life Science Equipment and Consumables 329.65M 17.9%

By Geography

Chart

• Mainland China 1.33B 87.2%
• Others 196.01M 12.8%

Fiscal year ended Dec 31, 2025 See the full Austar Lifesciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.53B	30.27M	2.02%
Dec 31, 2024	1.50B	-263.33M	-14.93%
Dec 31, 2023	1.76B	-393.14M	-18.23%
Dec 31, 2022	2.16B	141.84M	7.04%
Dec 31, 2021	2.02B	719.05M	55.48%

Data Source: S&P Global Market Intelligence Last updated: Sep 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 21, 2026

Data Sources Report a data error